Additional file 2 of Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients

Additional file 2: Table S1. The ionization modes and ion pairs of the metabolites. Table S2. The ionization modes and ion pairs of the lipid species. Table S3. Clinical baseline data of patients in the validation cohort. Table S4. One factor logistic regression of diabetes in the discovery cohort. Table S5. One factor logistic regression of diabetes in the validation cohort. Table S6. Multivariate logistic regression of diabetes in the discovery cohort. Table S7. Multivariate logistic regression of diabetes in the validation cohort. Table S8. Multivariate logistic results of candidate characteristic metabolites in two cohort. Table S9. Multivariate logistic results of characteristic metabolites in two cohorts. Table S10. Relationship between plasma glucose and metabolites associated with diabetes. Table S11. Relationship between plasma HbA1c and metabolites associated with diabetes. Table S12. Difference in transcription levels after PA treatment (P<0.05). Table S13. Difference in transcription levels after L-PA treatment (P<0.05). Table S14. KEGG pathway analysis of DEGs in NC vs. PA. Table S15. KEGG pathway analysis of DEGs in NC vs. L-PA. Table S16. Feature inclusion frequency using LASSO based feature selection for death prediction. Table S17. Model performance measures (95% CIs) for death prediction.